: iStockAnalyst.com Symbols Feed

Teva Pharmaceutical Industries Limited (NASDAQ:TEVA): A Good Buy

Fri, 02 Oct 2009 16:55:00 GMT

On September 30, Teva Pharmaceutical Industries Ltd (TEVA), sold the worldwide rights to a generic version of the white blood-cell boosting drug filgrastim to Hospira Inc (NYSE:HSP).[More...]

Daily Highlights: 9/18/09

Fri, 18 Sep 2009 12:41:24 GMT

Asian stocks fall as consumer finance firm Aiful seeks debt delay, Hong Kong warns of bank risks.EU officials press Obama on capping bank bonuses, tougher climate change.Euro-zone's surplus in its trade with the rest of the world hit a 7-year high in July.For the first time in nearly 2 years, American households grew a little wealthier in Q2.[More...]

Hospira Inc. (HSP): Prospects For Generic Drug Makers Improving

Thu, 17 Sep 2009 15:55:00 GMT

Generic-drug maker and hospital-supply company Hospira Inc. (HSP) boosted its financial guidance for 2009 on Thursday. Investors are cheering the news with a $0.99 or 2.35% rise in the stock price. Is the optimism warranted?[More...]

S&P 500 Stocks

Sun, 05 Apr 2009 01:35:00 GMT

The S&P 500 comprises of 500 large cap common stocks actively traded in the United States. The largees public companies that are traded on the New York Stock Exchange (NYSE) and NASDAQ are included in the S&P 500 index. The S&P 500 index was lunched in 1957 and is a value weighted index which is based on the 500 American stocks with the largest market capitalizations. The S&P 500 is the most widely followed index After the Dow Jones Industrial Average index and it is considered a barometer for the American economy. The S&P 500 index is included in the Index of Leading Indicators. There are the number of trading vehicle that are designed to follow the S&P 500 index. Hundreds of billions of US dollars have been invested in this index. The SPY (Exchange Traded Fund) is one of the most actively trading stock over the world. The Rydex,[More...]

Analysis Of Generic Drug Companies From India

Mon, 24 Nov 2008 16:14:00 GMT

The accompanying table includes the Top 25 rated companies with market caps over $50M U.S. Dollar which are included in the ETF Innovators (ETFI) Indian Generic Drug Index as a major component in the Global Generic Drug Index. The index also includes three companies based outside of India – Akorn (AKRX), Caraco Pharma (CPD), and Taro Pharma (TAROF). Akorn has a joint venture with Strides Arcolab (Akorn-Strides, LLC) which is focused on the hospital market for generic injectables, dominated by Hospira (HSP) and APP Pharma, which was acquired by Fresenius Medical (FMS).[More...]

Virtual Funds: Healthcare Fund's Ranking/Performance In Q3 '08 And Overall

Sat, 01 Nov 2008 17:26:00 GMT

Among all the sectors, healthcare has held up better than most. Of course, now, with the benefit of hindsight, various pundits and talking heads are pointing out that this is the safe haven with a lot of growth potential. What's the logic here? Since this sector has lost the least, it must grow the most now? Nonsense. If anything, now is probably not the time to invest in the healthcare considering the significance of upside potential in other, very beaten-down sectors. If you're nevertheless curious about what has done relatively well so far, here I will detail the performance of the virtual mutual fund I've set up for the Healthcare sector on the Marketocracy web site. Orange line in the chart below shows how my Healthcare Fund has performed relative to the m100 (a collective Marketocracy fund that uses picks from the top 100 members), S&P 500, Dow Jones Index, and Nasdaq. [More...]

Earnings Preview For Nov 3 - 7 - Earnings Preview

Sat, 01 Nov 2008 01:58:00 GMT

Companies that could issue positive surprises include Becton, Dickinson and Company (BDX), SucessFactors (SFSF) and Sunoco (SUN). Penn Virginia Corporation (PVA) could potentially disappoint investors. The Week's Events November has historically been one of the best months for the major markets, according to the[More...]

Analyst Comments: Align Tech, DeVry, Eni SpA, Finisar, Hospira, McDonald, Cleveland-Cliffs, Marlin Biz, Mobile TeleSystems, Salix Pharma, Potash Corp

Wed, 10 Sep 2008 21:42:00 GMT

We believe a difficult U.S. economy and higher marketing expenses will hamper Align Tech, Inc.?s (ALGN) topline growth and margins. Strong international growth and foreign exchange gains will help offset this. In the near-term, we think earnings quality could become an issue as the management finds it difficult to meet growth targets. Meaningful earnings growth will be pushed out to fiscal 2009 and 2010. We are reiterating the current Hold recommendation. We have adjusted our models to reflect the current economic environment. We expect fiscal 2008 sales growth of 10%, in-line with the management?s guidance of $309 million - $314 million. Heavier marketing spending may be necessary to drive GP channel penetration required to achieve management s growth targets. As a result, margin pressure can be expected, possibly leading to earnings quality issues.[More...]

Post Fed Earnings

Wed, 06 Aug 2008 14:33:00 GMT

Good morning. Investors are sorting through a number of earnings reports including from Cisco Systems (CSCO), Freddie Mac (FRE), Sprint (S), Time Warner (TWX), Priceline.com (PCLN), Ambac (ABK), & Whole Foods (WFMI). Also, oil is trading slightly higher ahead of the government's weekly energy inventory report at 10:35AM. In the early going, premarket futures are mixed as the market hopes to[More...]

Periodicals Wrap-Up for Thursday, July 11th

Fri, 11 Jul 2008 13:27:00 GMT

Rick Wagoner, the CEO of General Motors (GM), hit out against allegations that the auto maker may soon file for bankruptcy and said he believes the company’s financial position will “remain robust” for the rest of the year.[More...]

EDITORIAL: Money matters

Tue, 10 Nov 2009 19:12:00 GMT

Nov. 10--A crisis is a terrible thing to waste.
And lobbyists didn't during the budget stalemate that dragged on and on in Harrisburg as lawmakers and Gov. Ed Rendell tried to close the gap between revenue and spending.
Industries "wouldn't spend money like that if it didn't work," he told the paper, and that lobbying expenditures are "a key indicator of how Harrisburg really works: Invest a lot of money and you are going to have a lot more clout at the bargaining table."

: iStockAnalyst.com Symbols Feed

Teva Pharmaceutical Industries Limited (NASDAQ:TEVA): A Good Buy

Daily Highlights: 9/18/09

Hospira Inc. (HSP): Prospects For Generic Drug Makers Improving

S&P 500 Stocks

Analysis Of Generic Drug Companies From India

Virtual Funds: Healthcare Fund's Ranking/Performance In Q3 '08 And Overall

Earnings Preview For Nov 3 - 7 - Earnings Preview

Analyst Comments: Align Tech, DeVry, Eni SpA, Finisar, Hospira, McDonald, Cleveland-Cliffs, Marlin Biz, Mobile TeleSystems, Salix Pharma, Potash Corp

Post Fed Earnings

Periodicals Wrap-Up for Thursday, July 11th

EDITORIAL: Money matters

Hospira Profits Strong on Improved Efficiencies, Generic Drug Launch

Bad Power Cords Prompt Hospira Recall

Jobless Claims Set Record

Jobless claims set new record; GDP down more in 4Q - Mar 26 2009 5:02PM

Total jobless benefit rolls top 5.5M - Mar 26 2009 3:02PM

Jobless claims set new record; GDP down more in 4Q - Mar 26 2009 2:04PM

Total jobless benefit rolls top 5.5M - Mar 26 2009 12:32PM

Jobless claims set new record; GDP down more in 4Q - Mar 26 2009 11:06AM

More than 5.5 million are getting jobless benefits

BioTime CEO Dr. Michael West to Ring The Opening Bell at the New York Stock Exchange

BioTime, Inc. Announces Third Quarter 2009 Financial Results and Update on Recent Developments

Analyst Choice Initiates Market Analysis on Healthcare, Technology and Consumer Goods Sectors

BioTime, Inc. Announces Approval For NYSE Amex Listing

RidgewaterEquity.Com Free Fundamental Sector &Amp; Market Research on AGO, PTN, BJ, DTE, ZQK and HSP

StockPreacher.Com Issues Trading Outlook for Novadel Pharma Inc.

BenchmarkJournal.Com Free Analyst Review for AU, DOV, HSP, SNY, TCK and S

Hospira Launches Generic Oxaliplatin Injection

Hospira Reports Second-Quarter 2009 Results

Hospira Reports Second-Quarter 2009 Results

Form 4 HOSPIRA INC For: Nov 30 Filed by: Werner Thomas E (10K)

Form 4 HOSPIRA INC For: Nov 30 Filed by: Ramachandra Sumant (10K)

Form 4 HOSPIRA INC For: Nov 13 Filed by: Ramachandra Sumant (10K)

Form 4 HOSPIRA INC For: Nov 13 Filed by: Werner Thomas E (10K)

Form 3 HOSPIRA INC For: Nov 09 Filed by: Jones Daphne E (10K)

Form 4 HOSPIRA INC For: Nov 05 Filed by: Kearney Terrence C (10K)

Form 4 HOSPIRA INC For: Oct 30 Filed by: Ramachandra Sumant (10K)

Form 4 HOSPIRA INC For: Oct 30 Filed by: Werner Thomas E (10K)

Form 4 HOSPIRA INC For: Oct 19 Filed by: Kearney Terrence C (10K)

Form 4 HOSPIRA INC For: Oct 16 Filed by: Ramachandra Sumant (10K)